A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers
暂无分享,去创建一个
D. Camidge | A. Hughes | H. Swaisland | N. Barrass | J. Foster | J. Growcott | D. Smethurst | S. Febbraro | Nigel C. Barrass